Note: If you use other eye drops in addition to Restasis, you can probably still use those drops while you’re using Restasis. But make sure to check with your doctor about which eye drops are safe to ...

You may qualify for free Restasis through the drug’s manufacturer, myAbbVie Assist. That said, you won’t use your Medicare coverage. Restasis (cyclosporine), a brand-name eye drop for chronic dry eyes ...

Yes, people with Medicare Part D who use Restasis may be eligible for a patient assistance program called myAbbVie Assist. This article discusses whether Medicare covers Restasis, Medicare ...

Please provide your email address to receive an email when new articles are posted on . Allergan announced it has received FDA approval for Restasis Multidose, a preservative-free, multidose bottle ...

-- New Delivery System Will Now Provide RESTASIS ® in a Preservative Free, Easy-to-Use, Multi-Dose Bottle-- -- RESTASIS the Only* Health Canada Approved Treatment to Help Patients Produce More of ...

Patients treated with a single interventional eyelid procedure enabled by TearCare® technology after receiving Restasis® for the first six months of the trial realized clinically meaningful ...

The Food and Drug Administration has approved the first generic version of AbbVie Inc.’s dry-eye drug Restasis, or cyclosporine ophthalmic emulsion (eye drops). The generic cyclosporine ophthalmic ...

The Food and Drug Administration has approved Mylan’s generic Restasis (cyclosporine ophthalmic emulsion) 0.05% single-use vials (eye drops) to increase tear production in patients whose tear ...

Sight Sciences Inc (NASDAQ:SGHT) released the six-month SAHARA randomized controlled trial comparing interventional eyelid procedures enabled by TearCare Technology to Restasis for dry eye disease.

On Wednesday, the U.S. Food and Drug Administration announced approval to Mylan Pharmaceuticals for a generic form of Allergan's RESTASIS® (Cyclosporine Ophthalmic Emulsion 0.05%) product for ...